Why Mounjaro Is Expensive
Mounjaro (tirzepatide) is a prescription injectable for weight management and type 2 diabetes. Its high price reflects research and manufacturing costs, and many commercial plans place it in a higher tier, leading to large copays or full self-pay costs if coverage is limited or absent.
Can't Afford Mounjaro: Common Barriers
People who can't afford Mounjaro often face high list prices, limited insurance coverage, or prior authorization hurdles. Without strong coverage, monthly costs can be unmanageable, especially for long-term use. Manufacturer coupons or savings cards may lower out-of-pocket costs for eligible patients, but they usually cannot be combined with government insurance programs.
Options and Alternatives If You Can't Afford Mounjaro
If you can't afford Mounjaro, discuss alternatives with a healthcare provider. Options may include other weight-management medications, different dosing schedules, or lifestyle programs that reduce overall costs. You can also check the manufacturer's website for patient assistance programs, and review FDA-approved medication guides for safety and cost details at https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214605s000lbl.pdf.
